Clinical Trials Directory

Trials / Completed

CompletedNCT06288529

EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY

PROTECTIVE EFFECT OF SGLT2 INHIBITORS ON POST-CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY IN DIABETIC AND CKD PATIENTS

Status
Completed
Phase
Study type
Observational
Enrollment
975 (actual)
Sponsor
University of Health Sciences Balikesir Hospital Eduation and Research · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Chronic kidney disease and type 2 diabetes mellitus patients are with in high-risk patients in coronary arterial diseases and increasing number of coronary angiography and coronary interventional procedures have been performed in these population. As well as the risk factors have been identified by many studies preventive measures are lacking. In our study we found that SGLT2 inhibitors are beneficial in terms of reducing contrast media induced acute kidney injury in both diabetic and CKD patients.This is one of the leading studies in the literature pointing that SGLT2 inhibitors may have a potentially beneficial role in reducing or preventing the development of PC-AKI.

Conditions

Timeline

Start date
2023-07-15
Primary completion
2023-12-31
Completion
2024-01-31
First posted
2024-03-01
Last updated
2024-03-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06288529. Inclusion in this directory is not an endorsement.

EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY (NCT06288529) · Clinical Trials Directory